Yada, M., Miyazaki, M., Motomura, K., Masumoto, A., Nakamuta, M., Kohjima, M., . . . Kotoh, K. (2016). The prognostic role of lactate dehydrogenase serum levels in patients with hepatocellular carcinoma who are treated with sorafenib: The influence of liver fibrosis. J Gastrointest Oncol.
Dyfyniad Arddull ChicagoYada, Masayoshi, et al. "The Prognostic Role of Lactate Dehydrogenase Serum Levels in Patients With Hepatocellular Carcinoma Who Are Treated With Sorafenib: The Influence of Liver Fibrosis." J Gastrointest Oncol 2016.
Dyfyniad MLAYada, Masayoshi, et al. "The Prognostic Role of Lactate Dehydrogenase Serum Levels in Patients With Hepatocellular Carcinoma Who Are Treated With Sorafenib: The Influence of Liver Fibrosis." J Gastrointest Oncol 2016.